We help veterinary professionals and those who look after animals all around the world to achieve the highest possible standards of health and wellbeing for the animals in their care. We research, develop, manufacture and supply vaccines, pharmaceutical medicines and other animal health products, together with the equipment, training, technical support and specialised services to ensure their optimal use.
Our business is organised around four areas: poultry, swine, ruminants and companion animals.
Our “Together, Beyond Animal Health” vision emphasizes that the health and wellbeing of people, animals and our planet are totally interlinked.
It’s not about us, it’s about our customers. We listen and learn from them delivering solutions specific to their individual challenges and needs.
Passionate means putting our feelings into “hands on” service that goes beyond the normal and building long-term partnerships.
We are fully dedicated to prevent and treat diseases of all animals.
Together, we create an environment which encourages everyone to make decisions and assume responsibility for them.
In an increasingly complex and competitive world, we are able to get straight to the point without losing sight of our long-term ambitions.
We promote a culture of courage that allows us to continually move forwards, forge new paths, keep our promises and achieve our common goals, while always learning from our mistakes.
Innovation is embedded in our performance.
We identify the unmet needs of today, to meet the challenges of tomorrow by developing practical solutions.
Being innovative goes beyond product innovation and means constantly challenging ourselves to find new ways of creating added value.
We are a team of committed professionals working Together, beyond animal health, who are continuously encouraged to grow and making people grow through our interactions with the outside world.
We create collective performance by promoting trust and team spirit.
As the One Ceva community, we overcome adversity by coming together in difficult times.
In 1999, two French pharmaceutical companies, Sanofi and Synthélabo, merged to form Sanofi-Synthélabo. Soon afterwards the new company divested its animal health and nutrition business. This business was acquired through a leveraged management buyout. This resulted in the establishment of Ceva Santé Animal with its headquarters in Libourne, near Bordeaux.
In 2007, Ceva management and employees, many of them qualified and experienced veterinarians, became majority shareholders in the company’s third financing round.
Ceva inherited a rich history of vaccine making through its European subsidiary, Ceva Phylaxia. Founded in Hungary in 1912, the Phylaxia Vaccine Production Cie produced the first vaccine against classical swine fever. World famous scientists including József Marek and Aladár Aujeszky were closely associated with the company.
Over time we have become a truly global research-based business and a recognised leader and pioneer in areas as diverse as hatchery vaccination, reproductive management of farm animals and behavioural control products for dogs and cats.
This growth has been achieved both organically and through carefully chosen strategic acquisitions of companies from all around the world.
Over the past 20 years, we became the world’s fifth largest veterinary pharmaceutical company, and became the leading French animal health company.